<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl8596</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-8596</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клинические случаи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Case Reports</subject></subj-group></article-categories><title-group><article-title>Нарушение формирования пола 46,XY, ассоциированное с мутациями в гене MAP3K1. Описание клинических случаев</article-title><trans-title-group xml:lang="en"><trans-title>Disorder of sex development 46,XY associated with mutations in the gene MAP3K1. The report of clinical cases</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9695-0806</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Копылова</surname><given-names>Ирина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Kopylova</surname><given-names>Irina V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н.</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">iv_kopylova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1218-0742</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>Елена Станиславовна</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>Elena S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>педиатр-эндокринолог Института Детской Эндокринологии </p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">staykova.elena@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4915-1267</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чугунов</surname><given-names>Игорь Сергеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Chugunov</surname><given-names>Igor S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, старший научный сотрудник Института Детской Эндокринологии</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">chugunovigor@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1872-1792</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлова</surname><given-names>Елизавета Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Orlova</surname><given-names>Elizaveta M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, ведущий научный сотрудник Института Детской Эндокринологии </p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">elizaveta.orlova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5656-1382</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Даниленко</surname><given-names>Олег Сергеевич</given-names></name><name name-style="western" xml:lang="en"><surname>Danilenko</surname><given-names>Oleg S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, детский хирург отделения хирургии </p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">oleg.danilenco@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3734-6510</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бровин</surname><given-names>Дмитрий Николаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Brovin</surname><given-names>Dmitry N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, детский уролог-андролог, детский хирург отделения хирургии</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">brovin-dn@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1320-6561</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Карева</surname><given-names>Мария Андреевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kareva</surname><given-names>Maria A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, зав. детским отделением опухолей эндокринной системы</p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">i_marusya@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5507-4627</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петеркова</surname><given-names>Валентина Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Peterkova</surname><given-names>Valentina A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>главный детский эндокринолог Минздрава России, академик РАН, д.м.н., профессор, директор Института Детской Эндокринологии </p></bio><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><email xlink:type="simple">peterkova@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБУ &amp;laquo;Национальный медицинский исследовательский центр эндокринологии&amp;raquo; Минздрава России&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Endocrinology Research Centre&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>09</day><month>04</month><year>2018</year></pub-date><volume>64</volume><issue>1</issue><fpage>45</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Копылова И.В., Кузнецова Е.С., Чугунов И.С., Орлова Е.М., Даниленко О.С., Бровин Д.Н., Карева М.А., Петеркова В.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Копылова И.В., Кузнецова Е.С., Чугунов И.С., Орлова Е.М., Даниленко О.С., Бровин Д.Н., Карева М.А., Петеркова В.А.</copyright-holder><copyright-holder xml:lang="en">Kopylova I.V., Kuznetsova E.S., Chugunov I.S., Orlova E.M., Danilenko O.S., Brovin D.N., Kareva M.A., Peterkova V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/8596">https://www.probl-endojournals.ru/jour/article/view/8596</self-uri><abstract><p>Причинами нарушения формирования пола (НФП) 46,XY могут быть мутации ряда генов, вовлеченных в процесс дифференцировки гонад. XY-инверсия пола может являться также следствием нарушений на уровне гена митоген-активированной протеинкиназы (MAPK) киназы киназы 1 (MAP3K1) и MAPK-сигнального пути. В последнее десятилетие было доказано участие MAPK-пути в инициации экспрессии гена SRY при формировании мужского гонадного пола у млекопитающих. Роль MAPK-сигнального пути в формировании пола у людей изучена недостаточно. Вероятно, MAP3K1 и MAPK-сигнальный путь являются одним из генетических путей, контролирующих нормальное развитие яичек. В настоящее время в литературе описано несколько семей и спорадических случаев НФП 46,XY вследствие мутаций в гене MAP3K1. Клиническая картина НФП у этих пациентов различна и варьирует от женского фенотипа с правильным строением наружных гениталий до мужского фенотипа с гипоспадией. Мы приводим описания редких клинических случаев нарушений формирования пола 46,XY (семейный случай НФП у единоутробных сестер и спорадический случай) с не описанными ранее мутациями в гене MAP3K1. В статье также кратко анализируется литература по данной патологии.</p></abstract><trans-abstract xml:lang="en"><p>The disorders of sex development (DSD) 46,XY may be caused by mutations in a number of genes involved in the gonadal differentiation. The XY sex inversion can be also due to disturbances at the level of mitogen-activated protein kinase (MAPK) kinase kinase 1 gene (MAP3K1) and MAPK-signaling pathway. During the last decade, the involvement of the MAPK pathway in the SRY gene up-regulation during the formation of male gonadal sex in mammals has been demonstrated. The role of MAPK-signaling pathway in the human sex determination is not fully understood. Probably, MAP3K1 and the MAPK-signaling pathway are one of the genetic pathways controlling normal development of human testis. So far, several families and sporadic cases of 46,XY DSD due to mutations in MAP3K1 gene have been reported in the literature. Clinical presentation of DSD in these patients varies from female phenotype with normal externalia to male phenotype with hypospadias. We describe rare cases of the DSD 46,XY (a family case of DSD in uterine sisters and a sporadic case) with mutations in the MAP3K1 gene that haven’t been previously described. The article also presents brief literature review on this pathology.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>нарушение формирования пола</kwd><kwd>дисгенезия гонад</kwd><kwd>ген MAP3K1</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>disorders of sex development</kwd><kwd>gonadal dysgenesis</kwd><kwd>MAP3K1 gene</kwd><kwd>case report</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Молекулярно-генетическое исследование на панель генов «нарушение формирования пола» выполнено при содействии Фонда поддержки и развития филантропии «КАФ».</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hughes IA, Houk C, Ahmed Sf, et al. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-563. doi: 10.1136/Adc.2006.098319</mixed-citation><mixed-citation xml:lang="en">Hughes IA, Houk C, Ahmed Sf, et al. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-563. doi: 10.1136/Adc.2006.098319</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Jost A, Vigier B, Prepin J, Perchellet Jp. Studies on sex differentiation in mammals. Recent Prog Horm Res. 1973;29:1-41.</mixed-citation><mixed-citation xml:lang="en">Jost A, Vigier B, Prepin J, Perchellet Jp. Studies on sex differentiation in mammals. Recent Prog Horm Res. 1973;29:1-41.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bashamboo A, Mcelreavey K. Human sex-determination and disorders of sex-development (DSD). Semin Cell Dev Biol. 2015;45:77-83. doi: 10.1016/J.Semcdb.2015.10.030</mixed-citation><mixed-citation xml:lang="en">Bashamboo A, Mcelreavey K. Human sex-determination and disorders of sex-development (DSD). Semin Cell Dev Biol. 2015;45:77-83. doi: 10.1016/J.Semcdb.2015.10.030</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Pearlman A, Loke J, Le Caignec C, et al. Mutations in Map3k1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet. 2010;87(6):898-904. doi: 10.1016/J.Ajhg.2010.11.003</mixed-citation><mixed-citation xml:lang="en">Pearlman A, Loke J, Le Caignec C, et al. Mutations in Map3k1 cause 46,XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet. 2010;87(6):898-904. doi: 10.1016/J.Ajhg.2010.11.003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Das DK, Rahate SG, Mehta BP, et al. Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex development. Indian J Hum Genet. 2013;19(4):437-442. doi: 10.4103/0971-6866.124372</mixed-citation><mixed-citation xml:lang="en">Das DK, Rahate SG, Mehta BP, et al. Mutation analysis of mitogen activated protein kinase 1 gene in Indian cases of 46,XY disorder of sex development. Indian J Hum Genet. 2013;19(4):437-442. doi: 10.4103/0971-6866.124372</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Karandikar M, Xu S, Cobb Mh. MEKK1 binds raf-1 and the ERK2 cascade components. J Biol Chem. 2000;275(51):40120-40127. doi: 10.1074/Jbc.M005926200</mixed-citation><mixed-citation xml:lang="en">Karandikar M, Xu S, Cobb Mh. MEKK1 binds raf-1 and the ERK2 cascade components. J Biol Chem. 2000;275(51):40120-40127. doi: 10.1074/Jbc.M005926200</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153-183. doi: 10.1210/Edrv.22.2.0428</mixed-citation><mixed-citation xml:lang="en">Pearson G, Robinson F, Beers Gibson T, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153-183. doi: 10.1210/Edrv.22.2.0428</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Roberts PJ, Der CJ. Targeting rhe Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291-3310. doi: 10.1038/Sj.Onc.1210422</mixed-citation><mixed-citation xml:lang="en">Roberts PJ, Der CJ. Targeting rhe Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291-3310. doi: 10.1038/Sj.Onc.1210422</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bogani D, Siggers P, Brixey R, et al. Loss of mitogen-activated protein kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. Plos Biol. 2009;7(9):E1000196. doi: 10.1371/Journal.Pbio.1000196</mixed-citation><mixed-citation xml:lang="en">Bogani D, Siggers P, Brixey R, et al. Loss of mitogen-activated protein kinase 4 (MAP3K4) reveals a requirement for MAPK signalling in mouse sex determination. Plos Biol. 2009;7(9):E1000196. doi: 10.1371/Journal.Pbio.1000196</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gierl MS, Gruhn WH, Von Seggern A, et al. GADD45G functions in male sex determination by promoting p38 signaling and Sry expression. Dev Cell. 2012;23(5):1032-1042. doi: 10.1016/J.Devcel.2012.09.014</mixed-citation><mixed-citation xml:lang="en">Gierl MS, Gruhn WH, Von Seggern A, et al. GADD45G functions in male sex determination by promoting p38 signaling and Sry expression. Dev Cell. 2012;23(5):1032-1042. doi: 10.1016/J.Devcel.2012.09.014</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Warr N, Carre GA, Siggers P, et al. GADD45gamma and Map3k4 interactions regulate mouse testis determination via p38 MAPK-mediated control of Sry Expression. Dev Cell. 2012;23(5):1020-1031. doi: 10.1016/J.Devcel.2012.09.016</mixed-citation><mixed-citation xml:lang="en">Warr N, Carre GA, Siggers P, et al. GADD45gamma and Map3k4 interactions regulate mouse testis determination via p38 MAPK-mediated control of Sry Expression. Dev Cell. 2012;23(5):1020-1031. doi: 10.1016/J.Devcel.2012.09.016</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Szczepankiewicz A, Sobkowiak P, Rachel M, et al. Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case-control study. J Asthma. 2012;49(4):329-335. doi: 10.3109/02770903.2012.669442</mixed-citation><mixed-citation xml:lang="en">Szczepankiewicz A, Sobkowiak P, Rachel M, et al. Multilocus analysis of candidate genes involved in neurogenic inflammation in pediatric asthma and related phenotypes: a case-control study. J Asthma. 2012;49(4):329-335. doi: 10.3109/02770903.2012.669442</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Warr N, Bogani D, Siggers P, et al. Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP31K1. Plos One. 2011;6(5):E19572. doi: 10.1371/Journal.Pone.0019572</mixed-citation><mixed-citation xml:lang="en">Warr N, Bogani D, Siggers P, et al. Minor abnormalities of testis development in mice lacking the gene encoding the MAPK signalling component, MAP31K1. Plos One. 2011;6(5):E19572. doi: 10.1371/Journal.Pone.0019572</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Charlaftis N, Suddason T, Wu X, et al. The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. Embo J. 2014;33(21):2581-2596. doi: 10.15252/Embj.201488351</mixed-citation><mixed-citation xml:lang="en">Charlaftis N, Suddason T, Wu X, et al. The MEKK1 PHD ubiquitinates TAB1 to activate MAPKs in response to cytokines. Embo J. 2014;33(21):2581-2596. doi: 10.15252/Embj.201488351</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
